Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency
- 6 April 2011
- journal article
- Published by Wiley in Transfusion
- Vol. 51 (10) , 2237-2243
Abstract
BACKGROUND: It has been postulated that blood group O subjects may be partially protected against thrombotic thrombocytopenic purpura (TTP) because they have lower plasma levels of von Willebrand factor.STUDY DESIGN AND METHODS: The Oklahoma TTP Registry enrolled 301 consecutive patients from November 13, 1995 (when systematic ADAMTS13 measurements began), through 2009; 281 (93%) patients had ADAMTS13 measurements. Patients were designated as having severe ADAMTS13 deficiency when the activity measurement by either method was less than 10%. ABO blood group was determined in all 281 patients. The observed frequency of blood group O was compared to the expected frequency. The association between severe ADAMTS13 deficiency and blood group, race, sex, and age were analyzed by logistic regression.RESULTS: The frequency of blood group O was unexpectedly and significantly greater than the race‐ethnicity–adjusted expected frequency in 65 patients with severe ADAMTS13 deficiency (60.0% vs. 47.4%, p = 0.042) but not in 216 patients without severe ADAMTS13 deficiency (44.9% vs. 46.5%, p = 0.639). Blood group O and race‐ethnicity were independently associated with severe ADAMTS13 deficiency among patients with TTP. The probability for severe ADAMTS13 deficiency was 45.8% with O and 32.1% with non‐O blood groups for black patients and 24.1% with O and 15.1% with non‐O blood groups for white patients.CONCLUSION: Among patients with TTP and severe ADAMTS13 deficiency the relative frequency of patients with blood group O was greater than expected, suggesting that blood group O may be a risk factor for TTP associated with severe ADAMTS13 deficiency.Keywords
This publication has 26 references indexed in Scilit:
- Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic‐uremic syndromesAmerican Journal of Hematology, 2010
- Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage siteBlood, 2009
- An inquiry into the relationship between ABO blood group and thrombotic thrombocytopenic purpuraVox Sanguinis, 2009
- ABO genotype and risk of thrombotic events and hemorrhagic strokeJournal of Thrombosis and Haemostasis, 2009
- Effect of blood group on idiopathic thrombotic thrombocytopenic purpuraJournal of Clinical Apheresis, 2009
- Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)Journal of Thrombosis and Haemostasis, 2008
- A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factorBlood, 2008
- ABO(H) blood groups and vascular disease: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis, 2008
- Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysisBlood, 2005
- Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpuraBlood, 2002